Product Launch (Blog)

Jan, 09 2024

Bacteriophage Therapy: Harnessing Viral Predators for Precision and Targeted Antibacterial Treatment in Modern Medicine

The global bacteriophages therapy market is a transformative segment in modern medicine, leveraging viral predators to combat bacterial infections. Bacteriophages, or phages, are viruses that selectively target and destroy bacteria. This therapy represents a promising alternative to traditional antibiotics, addressing the challenge of antibiotic resistance. The evolving landscape of infectious disease management sees bacteriophage therapy as a pioneering approach with the potential to reshape bacterial infection treatment strategies globally.

Data Bridge Market Research analyses that the Global Bacteriophages Therapy Market was USD 39.80 million in 2021 and is expected to reach USD 64.40 million by 2029, registering a CAGR of 6.20% during the forecast period of 2022 to 2029.

"Increasing investment for healthcare infrastructure drives the market growth"

The increasing investment in healthcare infrastructure is a pivotal driver for the bacteriophages therapy market, facilitated by rising healthcare expenditure. Expanded financial allocations enable enhancing healthcare facilities, laboratories, and research centers dedicated to bacteriophage therapy. Improved infrastructure, equipped with state-of-the-art technologies, fosters research, clinical trials, and the development of bacteriophage-based treatments. This robust healthcare infrastructure accelerates therapeutic advancements and facilitates the integration of bacteriophage therapy into mainstream medical practices, addressing bacterial infections more effectively.

What restraints the growth of the global bacteriophages therapy market?

" High cost associated with technology hamper the market growth"

The high cost linked to bacteriophages therapy substantially hinders the growth rate of the market from 2022 to 2029. The financial burden of the therapy, encompassing production, purification, and administration costs, makes it less economically viable for widespread adoption. This impediment limits accessibility, hindering the market's expansion. The elevated expenses associated with bacteriophages therapy present a significant challenge, obstructing its potential to become a more widely utilized and economically feasible treatment option.

Segmentation: Global Bacteriophages Therapy Market

The global bacteriophages therapy market is segmented on the basis of target, type, base, application, route of administration, end-user, and distribution channel. 

  • On the basis of target, the global bacteriophages therapy market is segmented into escherichia coli, staphylococcus, streptococcus, pseudomonas, salmonella, and others
  • On the basis of type the global bacteriophages therapy market is segmented into lytic, and lysogenic
  • On the basis of base, the global bacteriophages therapy market is segmented into sterile broth culture, and water-soluble jelly base
  • On the basis of application, the global bacteriophages therapy market is segmented into bacterial dysentery, infections of skin and nasal mucosa, suppurative skin infection, lung and pleural infections, postoperative wound infections, and others
  • On the basis of route of administration, the global bacteriophages therapy market is segmented into oral, parenteral, rectal, dermal, and others
  • On the basis of end-user, the global bacteriophages therapy market is segmented into hospitals, specialty clinics, homecare, and others 
  • On the basis of distribution channel, the global bacteriophages therapy market is segmented into hospital pharmacy, retail pharmacy, online pharmacy, and others

Regional Insights: North America dominates the Global Bacteriophages Therapy Market

North America dominates the global bacteriophages therapy market, maintaining a leading market share and revenue. The region's sustained dominance is attributed to lytic bacteriophages' rapid recovery and therapeutic efficacy. Increased healthcare expenditure in North America is anticipated to drive further market growth. The presence of major key players and a growing adoption of newer technologies contribute to the region's continued prominence, ensuring the flourishing dominance of North America in the bacteriophages therapy market.

Asia-Pacific is poised to dominate the global bacteriophages therapy market, emerging as the fastest-growing region from 2022 to 2029. This dominance is attributed to heightened investment in innovative research and development for novel drug products. The ongoing development of healthcare infrastructure, coupled with rising government initiatives, propels the market's growth trajectory in the region. Asia-Pacific's pivotal role positions it at the forefront of advancements in bacteriophages therapy, shaping the landscape of bacterial infection treatment on a global scale.

To know more about the study, visit https://www.databridgemarketresearch.com/reports/global-bacteriophages-therapy-market

The Prominent Key Players Operating In The Global Bacteriophages Therapy Market Include:

  • Microgen (U.S.)
  • Micreos (Netherlands)
  • ATCC (U.S.)
  • Intralytix, Inc. (U.S.)
  • Adaptive Phage Therapeutics (U.S.)
  • Armata pharmaceuticals Inc. (U.S.)
  • LOCUS BIOSCIENCES, INC. (U.S.)
  • Delmont Laboratories, Inc. (U.S.)
  • Nextbiotics (U.S.)
  • Pherecydes Pharma (France)
  • iNtODEWORLD. Inc. (U.S.)
  • Enbiotix (U.S.)
  • Fixed-Phage Limited (U.K.)
  • Cytophage Technologies Inc. (Canada)
  • Eliava Bio Preparations LTD (U.S.)
  • Phagelux, Inc. (China)
  • InnoPhage, Ltd (Hong Kong)
  • TechnoPhage (Portugal)
  • Eligo Bioscience SA (France)
  • BiomX Ltd. (Israel)

Above are the key players covered in the report, to know about more and exhaustive list of global bacteriophages therapy market companies, contact: https://www.databridgemarketresearch.com/contact

Research Methodology: Global Bacteriophages Therapy Market

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.


Client Testimonials